Bluejay Diagnostics, Inc. BJDX
2.21 USD -0.08 (-3.49%)
Nov 5, 2026, 10:12 AM EST
2.21 Day range 2.30
1.84 52-week range 28.32
- YTD
- -79.29%
- 1 year
- -92.02%
Financial health
Altman Z-Score
-6.11 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -0.2×
FY 2019 5y median -6.7× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 0.2×
FY 2019 5y median 23.1× FY 2025
P/FCF -0.2×
FY 2019 5y median -7.4× FY 2025
EV/EBITDA 0.6×
FY 2019 5y median -7.1× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -519.4%
FY 2019 5y median -13.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -114.6%
FY 2019 5y median -114.6% FY 2025
ROIC -114.0%
FY 2019 5y median -114.0% FY 2025
ROA -96.2%
FY 2019 5y median -96.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income 3.0%
FY 2019 FY 2025
EPS (diluted) 96.7%
FY 2019 FY 2025
Free Cash Flow 23.4%
FY 2019 FY 2025
Financial Health
Current Ratio 4.9×
FY 2019 5y median 6.0× FY 2025
Quick Ratio 4.9×
FY 2019 5y median 6.0× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.8×
FY 2019 5y median 0.8× FY 2025
Interest Coverage -8287×
FY 2019 5y median -8.7× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31